Jonathan Slonin - Jul 20, 2021 Form 3 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: Chief Clinical Officer
Signature: /s/ Kristen Williams, Attorney-in-Fact
Stock symbol: PCRX
Transactions as of: Jul 20, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/30/2021, 04:16 PM
Next filing: Aug 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PCRX	Common Stock						21.4K	Jul 20, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PCRX	Stock Option (Right to Buy)							Jul 20, 2021	Common Stock	14.1K	$60.96	Direct	F2
holding	PCRX	Stock Option (Right to Buy)							Jul 20, 2021	Common Stock	37.5K	$52.37	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 16,905 unvested restricted stock units. The unvested restricted stock units vest as follows: (i) 5,655 restricted stock units that vest in four equal annual installments on June 3, 2022, June 3, 2023, June 3, 2024 and June 3, 2025, and (ii) 11,250 restricted stock units that vest in three equal annual installments on July 1, 2022, July 1, 2023 and July 1, 2024, in each case provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
F2	The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Content

Includes 16,905 unvested restricted stock units. The unvested restricted stock units vest as follows: (i) 5,655 restricted stock units that vest in four equal annual installments on June 3, 2022, June 3, 2023, June 3, 2024 and June 3, 2025, and (ii) 11,250 restricted stock units that vest in three equal annual installments on July 1, 2022, July 1, 2023 and July 1, 2024, in each case provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.